This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Results from NOR-SWITCH study support switch from Remicade® to Remsima®
Read more
New type of immunotherapy from Roche UK boosts survival in most common lung cancer
Read more
The Prostate Cancer Registry treatment outcomes data presented for the first time at ESMO 2016
Read more
Radiometer becomes a gold sponsor of the European Congress on Emergency Medicine
Read more
Automated breast ultrasound detects significantly more invasive cancers in dense breasts
Read more
Survey shows IPF patients happy with how they were informed about their diagnosis
Read more
Tecfidera® real-world studies affirm sustained efficacy and safety profile
Read more
Victoza® lowers progression of kidney damage in diabetic adults at high CV risk
Read more
Janssen receives CHMP positive opinion for Stelara® for moderately to severely active Crohn’s disease
Read more
NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old
Read more
Orphan drug designation granted to nintedanib for treatment of systemic sclerosis
Read more
New anaesthesia monitoring standards aim to improve patient safety
Read more
World first for robot eye operation
Read more
NHS urged to expand use of clinical care in the home
Read more
Saving lives and cutting costs in atrial fibrillation
Read more
Xofigo® recommended for prostate cancer with bone metastases in an additional group
Read more
Venetoclax receives positive opinion for chronic lymphocytic leukaemia in the UK
Read more
Page 139 of 200
« First
«
...
10
20
30
...
137
138
139
140
141
...
150
160
170
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: